Atomwise patented the first deep learning technology for structure-based small molecule drug discovery. This AI technology harnesses millions of data points and thousands of protein structures to solve problems that a human chemist would take many lifetimes to solve. We've partnered with some of the world’s largest pharmaceutical and agrochemical companies, and with more than 50 leading academic institutions and hospitals, to tackle the challenges of discovering and developing better drugs and chemicals.
Recently, Atomwise raised $45 million from leading venture capital firms to support the development and application of its AI technology. We’re at a critical time in history where our need for new kinds of medicines is greater than any time in human memory. Fortunately, we can leverage advancing technology and scientific breakthroughs to accelerate discovery. New data, new algorithms, new compute platforms lift all of us, enable our work on the hardest of problems, empower us to invent and create, and ultimately make the world a better place. Join us: www.atomwise.com/careers
B2B
51 to 100
Series B
$174.3M
Growth
2012
Healthcare
Drug Retail
Alternative Medicine
Structure based Drug Design and Discovery
Improve Hit Rates by Up to 10,000 Times, Better Medicines Faster
N/A
Yes
Active
Machine Learning
Natural Language Processing
Software
Technical Recruiter, Biotech and Pharma
San Francisco, California
Recruiting Coordinator
San Francisco, California
Head of Business Development, Platform Partnerships
San Francisco, California
Senior Medicinal Chemist
San Francisco, California
Senior Computational Chemist
San Francisco, California
AI/ML Professionals
Want to work at Atomwise?
We can introduce you to the right person at Atomwise
Potential Customers
Interested in what they do or partnership?
Learn more about how they work